Elanco Animal Health Inc
ELAN
查看详细走势图
22.305USD
+0.215+0.97%
收盘 12/19, 16:00（美东）报价延迟15分钟
11.08B总市值
308.38市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
+0.97%
5天
+4.77%
1月
+5.01%
6月
+65.71%
今年开始到现在
+84.19%
1年
+91.79%
查看详细走势图
TradingKey Elanco Animal Health Inc股票评分
单位: USD 更新时间: 2025-12-19操作建议
Elanco Animal Health Inc当前公司基本面数据相对健康，增长潜力很大。当前估值合理，在药品行业排名24/158位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价25.15。中期看，股价处于上升通道。近一个月，市场表现一般，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Elanco Animal Health Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
16
位分析师
买入
评级
25.154
目标均价
+15.97%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Elanco Animal Health Inc亮点
亮点风险
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
业绩转盈
公司业绩转盈，最新年度盈利美元
估值高估
公司最新PE估值308.31，处于3年历史高位
机构加仓
最新机构持股577.24M股，环比增加0.01%
查克·罗伊斯持仓
明星投资者查克·罗伊斯持仓，最新持仓市值602.56K
活跃度增加
近期活跃度增加，过去20天平均换手率1.06
Elanco Animal Health Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Elanco Animal Health Inc简介
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
公司代码ELAN
公司Elanco Animal Health Inc
CEOSimmons (Jeffrey N)
网址https://www.elanco.com/
常见问题
Elanco Animal Health Inc(ELAN)的当前股价是多少？
Elanco Animal Health Inc(ELAN)的当前股价是 22.305。
Elanco Animal Health Inc的股票代码是什么？
Elanco Animal Health Inc的股票代码是ELAN。
Elanco Animal Health Inc股票的52周最高点是多少？
Elanco Animal Health Inc股票的52周最高点是23.700。
Elanco Animal Health Inc股票的52周最低点是多少？
Elanco Animal Health Inc股票的52周最低点是8.020。
Elanco Animal Health Inc的市值是多少？
Elanco Animal Health Inc的市值是11.08B。
Elanco Animal Health Inc的净利润是多少？
Elanco Animal Health Inc的净利润为338.00M。
现在Elanco Animal Health Inc(ELAN)的股票是买入、持有还是卖出？
根据分析师评级，Elanco Animal Health Inc(ELAN)的总体评级为买入，目标价格为25.154。
Elanco Animal Health Inc(ELAN)股票的每股收益（EPS TTM）是多少
Elanco Animal Health Inc(ELAN)股票的每股收益（EPS TTM）是0.072。
相关品种
